> ## Content Index
> Fetch the complete content index at: https://www.therecursive.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Science4Beauty Raises €1.6M to Bring Its "Botox in a Cream" Beyond Poland
- URL: https://www.therecursive.com/science4beauty-seed-round-botox-cream-expansion/
- Published: 2026-09-03T09:57:08.000Z
- Updated: 2026-09-03T09:57:08.000Z
- Description: The Warsaw-based biotech behind Miorelaxant Magic™ raised €1.6M, led by 4growth VC with Hard2beat, to scale its recombinant conotoxin platform, a clinically proven, needle-free alternative to botox, and expand internationally.
- Author: The Recursive
- Tags: CEE, Deals, Science4Beauty, News

👯 **Founder(s):** Magdalena Janczewska (Co-founder & CEO), Anna Mazurkiewicz-Pisarek, PhD (Co-founder), Alina Mazurkiewicz (Co-founder), Agata Stefanek (Co-founder), alongside Prof. Tomasz Ciach (scientific advisor)

📅 **Founding year:** 2020

🏭 **Industry:** Biotech / cosmeceuticals

💥 **Problem:** People want the wrinkle-smoothing effect of botulinum toxin (Botox) without needles/injections, and to prolong the results of aesthetic procedures.

📣 **Solution:** A recombinant conotoxin, a bioactive molecule mimicking sea-snail venom that relaxes facial muscles and smooths wrinkles, delivering a needle-free "botox in a cream." Their flagship line is Miorelaxant Magic™ (clinically shown to cut wrinkle depth up to 48% and extend botox results \~60 days).

👥 **Customers:** Aesthetic medicine clinics, and individual consumers who can buy directly through the online store.

🎳 **Team size:** 2-10

🌱 **Stage:** Seed 

💰 **Investment amount:** €1.6M 

🚀 **Funded by:** 4growth VC (lead), Hard2beat, and business angels.

👁️‍🗨️ **Investor's perspective:** Tomasz Pasiewicz, Managing Partner at 4growth VC: *"At 4growth VC, we look for deep-tech companies – particularly in health and life sciences – that seamlessly combine breakthrough science with effective commercial execution. Science4Beauty meets these criteria entirely… We see immense potential in the innovative dermatology market and believe Science4Beauty has all the assets required to become a global player in the smart luxury segment."*

Konrad Trzyna, Managing Partner at Hard2beat: *"Science4Beauty is a prime example of leveraging synthetic biology and protein engineering for rapid commercialization… What attracted us is the platform potential of this technology and its entry into the medical-grade skincare market, combining the attractive margin profile of the beauty industry with the high entry barriers of the pharma sector."*

💡 **It will be spent on:** Scaling production/sales, accelerating R&D on additional bioactive molecules for dermatology and aesthetic medicine, and launching distribution in key international markets.

💬 **In their own words:** Magdalena Janczewska, CEO: *"Science4Beauty is not just a line of finished skincare products, but above all a complete and highly scalable biotechnology platform… We are working on new applications for our technology, including treatments for hyperhidrosis and dermatological conditions such as rosacea, as well as innovative delivery systems like microneedle patches."*

💪 **Their specialty:** Full in-house biotech platform that designs, produces and purifies recombinant proteins/peptides in its own certified Category I GMM genetic engineering lab; IP protected across 10 jurisdictions; clinically validated efficacy; pipeline into hyperhidrosis, rosacea and microneedle patches.

🔑 **Business model:** B2B sales to aesthetic clinics and DTC e-commerce

💸 **Funding so far:** €1.6M